Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by He Junli. Officer active across 2 companies, notably Biostage, Inc.. In total, 14 disclosures have been recorded. Breakdown: 13 buys · 1 sell. Total volume traded: €132k. Activity tracked since 12 December 2022. The latest transaction was filed on 25 November 2025 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to He Junli
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
135 shares@ US$6.83100.0% of flowCommon StockSEC:0001415889-23-000497:0
14 of 14 declarations
About He Junli
He Junli is CEO of Harvard Apparatus Regenerative Technology, Inc. and a Director of Biostage, Inc. The record shows 14 filings in total, and across the 14 sampled filings from 2023-01-05 to 2025-12-01, buys total EUR 131520 and sells total EUR 876, with Acquisition listed as the modal transaction nature.